Sex differences in cardiovascular outcomes in patients with incident hypertension

Journal of Hypertension

Volumn 31, Issue 2, 2013, Pages 271-277

  Daugherty, Stacie L ^a,b   Masoudi, Frederick A ^a,b   Zeng, Chan ^b   Michael Ho, P ^a,b,c   Margolis, Karen L ^d   O'Connor, Patrick J ^d   Go, Alan S ^b,e,f   Magid, David J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b KAISER PERMANENTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular outcomes; incident hypertension; sex

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENT HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84872842378     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835bdc44     Document Type: Article

References (32)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart Disease and Stroke Statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121:e46-e215.
2. Yusuf S, Hawken S,Ô unpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart Disease and Stroke Statistics-2009 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21-e181.
4. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138:S211-S219.
5. Gueyffier F, Boutitie F, Boissel J-P, Pocock S, Coope J, Cutler J, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med 1997; 126:761-767.
6. Antikainen R, Jousilathi P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middleaged population. J Hypertens 1998; 16:577-583.
7. Bakx JC, Veldstra MI, van den Hoogen HJM, Zielhuis GA, Thien T, van Weel C, van den Bosch WJHM. Blood pressure and cardiovascular morbidity and mortality in a Dutch population: the Nijmegen Cohort Study. Prevent Med 2001; 32:142-147.
8. Lloyd-Jones DM, Leip EP, Larson MG, Vasan RS, Levy D. Novel approach to examining first cardiovascular events after hypertension onset. Hypertension 2005; 45:39-45.
9. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, MacKenzie TD, et al. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant 2010; 25:801-807.
10. Shulman N, Ford CE, Hall W, Blaufox M, Simon D, Langford H, Schneider K. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 (Suppl 5):180-193.
11. Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant 2003; 18:2047-2053.
12. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11:319-329.
13. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 2006; 70:1694-1705.
14. Go AS, Magid DJ, Wells B, Sung SH, Cassidy-Bushrow AE, Greenlee RT, et al. The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes 2008; 1:138-147.
15. Ho PM, Zeng C, Tavel HM, Selby JV, O'Connor PJ, Margolis KL, Magid DJ. Trends in first-line therapy for hypertension in the Cardiovascular Research Network Hypertension Registry, 2002-2007. Arch Intern Med 2010; 170:912-913.
16. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med 1999; 159:2673-2677.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-1252.
18. Sarafidis Pa, Bakri, GL. Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: comment on 'intensive and standard blood pressure targets in patients with type 2 diabetes mellitus'. Arch Intern Med 2012; 172:1304-1305.
19. McBrien K, Rabi DM, Campbell N, Barnieh L, Clement F, Hemmelgarn BR, et al. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2012:1-8.
20. Selby JV, Lee J, Swain BE, Tavel HM, Ho PM, Margolis KL, et al. Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Hypertension 2010; 56:605-611.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. For the modification of diet in renal disease study G: a more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470.
22. Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008; 168:2466-2473.
23. Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, et al. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol 2011; 6:2605-2611.
24. Eriksen BO, Tomtum J, Ingebretsen OC. Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort. Nephron Clin Pract 2010; 115:E41-E50.
25. Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the ARIC study. Am J Epidemiol 2009; 170:414-424.
26. Fort J. Chronic renal failure: a cardiovascular risk factor. Kidney Int 2005; 68 (S99):S25-S29.
27. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease. Circulation 2007; 116:85-97.
28. Boggia J, Thijs L, Hansen TW, Li Y, Kikuya M, Bjorklund-Bodegard K, et al. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011; 57:397-405.
29. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55:1056-1065.
30. Daugherty SL, Ellis J, Masoudi FA, Ho PM, Schmittdiel JA, Tavel HM, Magid DJ. Age dependent gender differences in hypertension management. J Hypertens 2011; 29:1005-1011.
31. Nielsen W, Vestbo J, Jensen G. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9:175-180.
32. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998; 16:761-769.